POAIPredictive Oncology Inc.

Nasdaq predictive-oncology.com


$ 1.71 $ 0.00 (0 %)    

Friday, 17-May-2024 10:55:24 EDT
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 1.68
$ 1.66
$ 1.68 x 200
$ 0.00 x 0
$ 1.66 - $ 1.71
$ 1.12 - $ 7.12
29,290
na
6.89M
$ 1.95
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 03-28-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-21-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-31-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
13 05-12-2021 03-31-2021 10-Q
14 03-15-2021 12-31-2020 10-K
15 11-16-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 06-08-2020 03-31-2020 10-Q
18 04-01-2020 12-31-2019 10-K
19 11-15-2019 09-30-2019 10-Q
20 08-19-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-Q
22 04-01-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 04-02-2018 12-31-2017 10-K
27 11-14-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-15-2017 03-31-2017 10-Q
30 03-15-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-12-2016 06-30-2016 10-Q
33 05-23-2016 03-31-2016 10-Q
34 03-16-2016 12-31-2015 10-K
35 11-13-2015 09-30-2015 10-Q
36 08-10-2015 06-30-2015 10-Q
37 05-18-2015 03-31-2015 10-Q
38 04-30-2015 12-31-2014 10-K
39 11-12-2014 09-30-2014 10-Q
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 predictive-oncology-announces-progress-with-flugen-in-the-development-of-first-of-its-kind-intranasal-flu-vaccine-as-part-of-a-62m-phase-2b-grant-awarded-by-the-us-dod

Predictive Oncology Inc. (NASDAQ:POAI), a leader in AI-driven drug discovery and biologics, announces a collaboration with FluG...

 predictive-oncology-q4-eps-085-up-from-200-yoy-sales-33503k-down-from-36347k-yoy

Predictive Oncology (NASDAQ:POAI) reported quarterly losses of $(0.85) per share. This is a 57.5 percent increase over losses o...

 earnings-scheduled-for-november-14-2023

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...

 predictive-oncology-q3-eps-078-up-from-100-yoy-sales-71506k-up-from-45583k-yoy

Predictive Oncology (NASDAQ:POAI) reported quarterly losses of $(0.78) per share. This is a 22 percent increase over losses of ...

 predictive-oncology-completes-ai-driven-study-of-ovarian-cancer-with-upmc-magee-womens-hospital

Predictive Oncology Inc. (NASDAQ:POAI), a leader in AI-driven drug discovery and biologics, announced today that it has complet...

 predictive-oncology-says-on-august-14-bob-myers-cfo-notified-co-of-his-intent-to-resign-from-company-effective-september-30-josh-blacher-has-been-named-as-companys-interim-chief-financial-officer

- SEC Filing  

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION